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Soria-Go´mez et al. show that CB1
receptors expressed at presynaptic
terminals of medial habenula neurons
projecting to the interpeduncular nucleus
specifically control the expression of
aversivememories. This function requires
negative control of cholinergic, but not
glutamatergic, neurotransmission.
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Expression of aversive memories is key for survival,
but the underlying brain mechanisms are not fully un-
derstood. Medial habenular (MHb) axons corelease
glutamate and acetylcholine onto target postsyn-
aptic interpeduncular (IPN) neurons, but their role
in aversive memories has not been addressed so
far. We found that cannabinoid type 1 receptors
(CB1R), key regulators of aversive responses, are
present at presynaptic terminals of MHb neurons in
the IPN. Conditional deletion of CB1R from MHb
neurons reduces fear-conditioned freezing and abol-
ishes conditioned odor aversion in mice, without
affecting neutral or appetitively motivatedmemories.
Interestingly, local inhibition of nicotinic, but not glu-
tamatergic receptors in the target region IPN before
retrieval, rescues these phenotypes. Finally, optoge-
netic electrophysiological recordings of MHb-to-IPN
circuitry revealed that blockade of CB1R specifically
enhances cholinergic, but not glutamatergic, neuro-
transmission. Thus, presynaptic CB1R control ex-
pression of aversive memories by selectively modu-
lating cholinergic transmission at MHb synapses in
the IPN.
INTRODUCTION
The habenular complex is divided into the lateral (LHb) and the
medial portion (MHb) (Hikosaka, 2010) (Figures 1A and 1B),
and, by linking the limbic forebrain and the midbrain-extrapyra-
midal motor system, it regulates physiological and pathological
behaviors (Sandyk, 1991). Whereas the functions of the LHb
have been the focus of intense research (Geisler and Trimble,
2008; Hikosaka, 2010), less is known regarding the roles of the
MHb (Viswanath et al., 2013). Recent studies, however, revealed
that the MHb modulates locomotion and emotional responses
(Agetsuma et al., 2010; Hsu et al., 2014; Kobayashi et al.,306 Neuron 88, 306–313, October 21, 2015 ª2015 Elsevier Inc.2013; Yamaguchi et al., 2013). The main target of MHb neurons
is the mesencephalic interpeduncular nucleus (IPN) (Contesta-
bile et al., 1987) (Figure 1B). Selective modulation of this circuit
in zebrafish impacts on aversive responses (Agetsuma et al.,
2010). However, whether similar functions exist in the mamma-
lian brain is unknown.
Choline acetyl transferase (ChAT)-containing MHb neurons
(Contestabile et al., 1987) can corelease both acetylcholine
and glutamate onto target IPN neurons (Hu et al., 2012; Ren
et al., 2011). Nevertheless, the behavioral implications of this
corelease have not been investigated yet.
The CB1R are present in habenula neurons, but their subre-
gional location and their functions are unknown (Marsicano
and Kuner, 2008; Marsicano and Lutz, 1999; Matsuda et al.,
1993). CB1R and their endogenous ligands form the endocanna-
binoid system (ECS) (Piomelli, 2003), which, at synaptic level,
retrogradely decreases the release of several neurotransmitters
(Castillo et al., 2012; Degroot et al., 2006; Kano et al., 2009; Mar-
sicano and Lutz, 2006). Many functions of the MHb, such as the
regulation of aversivememories, are also under the control of the
ECS (Busquets-Garcia et al., 2015; Marsicano et al., 2002; Mor-
ena and Campolongo, 2014; Riebe et al., 2012). This suggests
that a control of the activity of the MHb-to-IPN circuit by presyn-
aptic CB1R might regulate aversive memories.
In this study, we analyzed whether CB1R in MHb neurons
(hereafter called MHb-CB1R) regulate aversive responses.
The results reveal that endocannabinoid control of MHb-to-IPN
cholinergic, but not glutamatergic, neurotransmission exerts a
necessary role in the expression of aversive memories.
RESULTS
Specific Deletion of the CB1 Gene in the MHb
CB1R are widely expressed in different brain regions (Herken-
ham et al., 1990; Marsicano and Kuner, 2008), including the
habenula (Marsicano and Lutz, 1999; Matsuda et al., 1993).
However, the exact localization of habenular CB1R mRNA
was not addressed. By fluorescent in situ hybridization (FISH),
we found that CB1R mRNA is present in the MHb and in
the adjacent paraventricular thalamic nucleus (PVT), whereas




Figure 1. CB1R are Expressed at Presynap-
tic Terminals of MHb Neurons Projecting to
the IPN
(A) Schematic drawing showing the localization of
the habenular complex and adjacent structures in
a coronal view of the mouse brain. (Inset) Fluo-
rescent in situ hybridization (FISH) micrograph
showing the expression of CB1R mRNA in the re-
gion. Green dotted line, MHb; yellow dotted line,
LHb (lateral habenula); orange dotted line, PVT
(paraventricular thalamus).
(B) Schematic representation of the MHb projec-
tion toward the IPN through the fasciculus retro-
flexus (fr) in a sagittal view of the mouse brain.
(Inset) Fluorescent immunohistochemistry coronal
micrograph (vertical dashed line) showing the
expression of CB1 protein in the IPN. Hipp, hip-
pocampus.
(C) Representative epifluorescent micrograph im-
ages from coronal sections showing the presence
of the anterograde tracer phaseolus vulgaris-leu-
coagglutinin (PHAL; left panel, red) previously in-
jected into the MHb (Figure S1; n = 3), and the CB1
receptor immunoreactivity (middle panel, green) in
the IPN. Note the strong colocalization (right
panels, yellow) in the middle part of the IPN. VTA,
ventral tegmental area.
(D) Representative FISH micrographs showing the
expression of CB1 receptor mRNA in control MHb-
CB1-WT (top panel) and mutant MHb-CB1-KO
mice (bottom panel). BLA, basolateral amygdala.
See also Figure S1.Figure S1A available online). Consistently, immunohistochem-
ical and tracing experiments showed that presynaptic CB1R
protein is present in the target region of MHb neurons, the IPN
(Figures 1B, 1C, and S1B).
Considering the importance of CB1R and MHb in the re-
gulation of aversive responses (Agetsuma et al., 2010; Hsu
et al., 2014; Kobayashi et al., 2013; Marsicano et al., 2002;
Morena and Campolongo, 2014; Riebe et al., 2012; Viswanath
et al., 2013), we addressed the specific role of CB1R in this
brain nucleus using conditional mutagenesis. We injected
adeno-associated viruses expressing Cre recombinase (AAV-
Cre) (Soria-Go´mez et al., 2014a) directly into the MHb of
CB1-floxed mice (Marsicano et al., 2003) to obtain MHb-
CB1-KO mice, lacking CB1R expression in MHb neurons. Fig-
ure 1D shows the expression of CB1R mRNA in control mice
injected with empty AAV vectors (MHb-CB1-WT mice) and
in MHb-CB1-KO littermates. MHb-CB1-KO mice presented a
deletion of CB1R mRNA in the MHb (Figures 1D and S1A; Ta-Neuron 88, 306–313,ble S2), but not in adjacent areas (e.g.,
PVT; Figures 1D and S1A; Table S2).
Role of MHb-CB1R in Aversive
Conditioning
MHb-CB1-KO mice displayed a strongly
reduced freezing response in cued and
contextual fear conditioning experiments
as compared toMHb-CB1-WT littermates(Figures 2A–2D; Table S1). Importantly, the mutation did not
affect potentially confounding related behaviors, such as pain
(shock) sensitivity, unconditioned freezing, locomotion, and anx-
iety-like behavior (Figures S2A–S2J; Table S2).
To test whether this function of MHb-CB1R extends to other
aversive memory tasks, we evaluated conditioned odor aversion
(COA) (Chapuis et al., 2007; Desgranges et al., 2009). Whereas
MHb-CB1-WT mice displayed a clear odor aversion, MHb-
CB1-KO littermates failed to express COA (Figure 2E; Table
S1). Control analyses revealed that liquid ingestion, odor percep-
tion, and neophobia were not affected by the mutation (Fig-
ure S2K; Table S2).
MHb-CB1-KO mice did not display any alteration in a su-
crose-conditioned odor preference task (appetitive memory;
Pinhas et al., 2012; Figure S2L; Table S2). In addition, the
same mice displayed normal novel object recognition memory
(‘‘neutral’’ memory; Puighermanal et al., 2009; Figures S2M




Figure 2. MHb-CB1R Are Necessary for
Aversive Memories
(A and B) Time course (A) and total (B) freezing
responses of MHb-CB1-KOmice (n = 6) and MHb-
CB1-WT controls (n = 7) undergoing cued fear
conditioning.
(C and D) Time course (C) and total (D) freezing
responses of MHb-CB1-KO mice (n = 11) and
MHb-CB1-WT controls (n = 9) undergoing con-
textual fear conditioning.
(E) Odorized water intakes of MHb-CB1-WT (n = 8)
and MHb-CB1-KO mice (n = 10) undergoing con-
ditioned odor aversion experiments. CS+, condi-
tioned odor; CS, neutral odor. Data, means ±
SEM. *p < 0.05; **p < 0.01, ***p < 0.001. For details
of statistical analyses, see Table S1. See also
Figure S2.in a fear-conditioning test (Figure S2O; Table S2). Finally, MHb-
CB1R deletion did not alter sucrose preference (Figure S2P; Ta-
ble S2).
Thus, MHb-CB1R signaling is necessary for aversive condi-
tioning based on different sensory modalities, but they are
dispensable for appetitive or ‘‘neutral’’ memory and sucrose
preference.
MHb-CB1R in the IPN Control the Expression of
Conditioned Freezing
The main mechanism of action of the ECS in the brain is the
negative control of presynaptic neurotransmitter release (Castillo
et al., 2012; Degroot et al., 2006; Kano et al., 2009; Marsicano
and Lutz, 2006; Piomelli, 2003). Thus, MHb-CB1R might modu-
late aversive memories by the presynaptic regulation of neuro-
transmission in the IPN.
Intra-IPN injections of the CB1R antagonist AM251 in wild-
type C57BL/6-N mice before retrieval of cued fear memory pro-
duced a dose-dependent reduction of freezing to levels very
similar to the ones of MHb-CB1-KO mice (Figures 3A, 3B,
S3A, and S3B; Tables S1 and S2), indicating that presynaptic
MHb-CB1R acutely control expression of aversive memories
in the IPN.308 Neuron 88, 306–313, October 21, 2015 ª2015 Elsevier Inc.MHb-CB1R-Dependent Decrease of
Cholinergic Transmission in the IPN
Mediates Expression of Aversive
Memories
MHb neurons can corelease glutamate
and acetylcholine onto IPN neurons (Hu
et al., 2012; Ren et al., 2011). Thus, the
phenotype of MHb-CB1-KO mice might
be due to the lack of CB1R-dependent
negative control of release, eventually
leading to an excess of either or
both neurotransmitters in the IPN. To
address this issue, we adopted intra-
IPN pharmacological approaches aimed
at reducing this potential excess of
neurotransmitter release (see Bellocchio
et al., 2010; Soria-Go´mez et al., 2014a).First, we performed dose-response experiments injecting the
NMDA receptor antagonist MK801, the AMPA receptor antag-
onist NBQX, or the nicotinic receptor antagonist mecamylamine
(MEC) into the IPN before retrieval test of cue-conditioned
C57BL/6-N mice. Higher doses (3 mg of MK801 or MEC,
0.1 mg of NBQX, respectively) reduced conditioned freezing
(Figures S3C–S3H; Table S2). However, lower doses (1 mg of
MK801 or MEC, and 0.05 mg of NBQX, respectively) were
devoid of any effect (Figures S3C–S3H; Table S2), and were
chosen as ‘‘subeffective’’ doses for further experiments. The
intra-IPN injection of 1 mg MK801 or 0.05 mg NBQX before
retrieval test did not alter tone-induced freezing of either condi-
tioned MHb-CB1-WT or MHb-CB1-KO mice (Figures 3C–3F;
Table S1). Conversely, intra-IPN infusion of 1 mg MEC had no
effect on MHb-CB1-WT controls, but it fully rescued the
freezing behavior of the mutants (Figures 3G and 3H; Table
S1), without altering locomotion (Figures S3I–S3K; Table S2)
or unconditioned freezing before tone presentation (Figure 3G).
Furthermore, the same treatment with MEC before COA test
also rescued the conditioned aversion of MHb-CB1-KO mice
(Figure 3I; Table S1).
These data indicate that CB1R-dependent control of
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MHb-to-IPN circuit mediates the expression of aversive mem-
ories, independently of the sensory modalities involved.
CB1R in the IPN Selectively Control Cholinergic
Transmission
Cholinergic/glutamatergic afferents from ventral MHb neurons
target mainly the medial part of the IPN, whereas dorsal MHb
neurons express Substance P and mainly project to the lateral
portions of the IPN (Eckenrode et al., 1987; Hsu et al., 2014;
Ren et al., 2011). Immunohistochemistry revealed that MHb-
CB1R deletion increased the number of cells expressing the
marker of neuronal activity c-Fos in themedial IPN, with no effect
in the lateral portion (Figures S4A and S4C; Table S2). Thus,
MHb-CB1R appear to exert a specific presynaptic control of
the activity of MHb cholinergic neurons in the medial IPN. To
directly test this possibility, we performed electrophysiological
recordings in IPN slices derived from mutant mice expressing
the light-gated cation channel ChannelRhodopsin-2 (ChR2),
exclusively in cholinergic neurons (ChAT-ChR2-EYFP mice; Fig-
ures S4D–S4F), which have been used to study the MHb-to-IPN
cholinergic pathway (Hu et al., 2012; Ren et al., 2011). Light-
induced stimulation of cholinergic terminals in these slices can
simultaneously evoke both acetylcholine and glutamate release
onto IPN neurons (Hu et al., 2012; Ren et al., 2011; Figure 4). The
application of the CB1R antagonist AM251was not able to signif-
icantly alter light-evoked presynaptic glutamatergic release in
the IPN (Figure 4A–4D; Table S1). In contrast, the same treat-
ment increased cholinergic neurotransmission evoked by photo-
stimulation (Figures 4E–4H; Table S1). Thus, presynaptic CB1R
control cholinergic, but not glutamatergic, neurotransmission in
the MHb-to-IPN pathway.
DISCUSSION
These data show that the expression of aversive memories is un-
der the control of CB1R in MHb neurons synapsing onto IPN
cells. Genetic deletion of MHb-CB1R and pharmacological inhi-
bition of CB1R activity in the IPN both result in reduced aversive
acquired responses, without altering appetitive or ‘‘neutral’’
memories. Thus, the ECS specifically controls the MHb-to-IPN
circuit to promote aversive memory expression. Our data indi-
cate a specific role ofMHb-CB1R in expression of aversivemem-
ories, but a role of these receptors in other phases of learningFigure 3. CB1R Mediate the Expression of Aversive Memories by Modu
(A and B) Time course (A) and total (B) freezing responses of C57Bl/6Nmice under
antagonist AM251 1 mg (n = 5), AM251 3 mg (n = 6), or vehicle (VEH, n = 15).
(C and D) Time course (C) and total (D) freezing responses of MHb-CB1-WT and
infusion of vehicle (VEH) or the glutamatergic NMDA receptor antagonist MK801
VEH, n = 11; MHb-CB1-KO MK801, n = 8.
(E and F) Time course (E) and total (F) freezing responses of MHb-CB1-WT and
infusion of vehicle (VEH) or the AMPA receptor antagonist NBQX (0.05 mg). MHb-C
CB1-KO NBQX, n = 9.
(G and H) Time course (G) and total (H) freezing responses of MHb-CB1-WT and
infusion of vehicle (VEH) or the nicotinic receptor antagonist mecamylamine (MEC
VEH, n = 11; MHb-CB1-KO MEC, n = 9.
(I) Odorized water intakes of MHb-CB1-WT and MHb-CB1-KO mice undergoing c
VEH orMEC (1 mg). CS+, conditioned odor; CS, neutral odor. Data, means ± SEM
S1. See also Figure S3.
310 Neuron 88, 306–313, October 21, 2015 ª2015 Elsevier Inc.(e.g., acquisition or consolidation) cannot be currently excluded.
However, MHb-CB1R are clearly necessary for the expression of
acquired aversive memories under different sensory modalities.
This physiological function of CB1R is surprising, because
large evidence indicates that the global genetic deletion or
systemic pharmacological blockade of CB1R during aversive
memory retrieval generally results in increased expression (or
decreased extinction) of conditioned freezing (Busquets-Garcia
et al., 2015; Marsicano et al., 2002; Morena and Campolongo,
2014; Riebe et al., 2012). Thus, the present data reveal poten-
tially opposite consequences of general endocannabinoid ac-
tions as compared to their regulation of specific circuits. Interest-
ingly, other recent studies revealed that the functions of CB1R
depend on the cell type(s) and the circuit(s) on which they are
activated (Busquets-Garcia et al., 2015). For instance, despite
a general hyperphagic role of the ECS (Bellocchio et al., 2010;
Di Marzo et al., 2001), certain populations of CB1R in specific
neuronal types and/or in specific circuits exert opposite func-
tions, either promoting or inhibiting food intake (Bellocchio
et al., 2010; Busquets-Garcia et al., 2015; Soria-Go´mez et al.,
2014a, 2014b). The present data suggest that, in front of a gen-
eral inhibitory function of the ECS on the expression of aversive
memories (Busquets-Garcia et al., 2015; Marsicano et al., 2002;
Morena and Campolongo, 2014; Riebe et al., 2012), MHb-CB1R
exert the opposite promoting function. This ‘‘polymodal’’ regula-
tion of behavior by CB1R represents an example of the emerging
self-regulatory and fine-tuned control of brain processes.
From the mechanistic point of view, our data consistently
indicate that MHb-CB1R mediate the expression of aversive
memories via selective presynaptic modulation of cholinergic,
but not glutamatergic transmission in the IPN. The behavioral
phenotypes of MHb-CB1-KO mice are fully rescued by partial
inhibition of nicotinic receptors in the IPN, but not by the
same approach targeting NMDA or AMPA glutamate receptors.
Considering the impact of CB1R on glutamatergic transmission
in other brain regions (Busquets-Garcia et al., 2015), it is still
possible that MHb-CB1R control other behaviors by modulating
glutamate release in the IPN. Consistent with the behavioral re-
sults, modulation of IPN acetylcholine, but not of glutamate
neurotransmission, is under the control of CB1R in electrophys-
iological settings. Corelease of glutamate by neurons that were
generally thought to use only modulatory neurotransmitters
such as acetylcholine, serotonin, or dopamine has been recentlylating Cholinergic, but Not Glutamatergic, Activity in the IPN
going cued fear conditioning after pretest intra-IPN infusion of the CB1 receptor
MHb-CB1-KO mice undergoing cued fear conditioning after pretest intra-IPN
(1 mg). MHb-CB1-WT VEH, n = 6; MHb-CB1-WT MK801, n = 8; MHb-CB1-KO
MHb-CB1-KO mice undergoing cued fear conditioning after pretest intra-IPN
B1-WT VEH, n = 6;MHb-CB1-WTNBQX, n = 6;MHb-CB1-KO VEH, n = 6;MHb-
MHb-CB1-KO mice undergoing cued fear conditioning after pretest intra-IPN
, 1 mg). MHb-CB1-WT VEH, n = 10; MHb-CB1-WT MEC, n = 6; MHb-CB1-KO
onditioned odor aversion (n = 7–13 per group) after pretest intra-IPN infusion of
. *p < 0.05; **p < 0.01; ***p < 0.001. For details of statistical analyses, see Table
A B C D
E F G H
Figure 4. CB1R Activity Specifically Regulates Cholinergic Transmission in the MHb-to-IPN Circuit
(A–D) The CB1R antagonist AM251 does not affect glutamatergic transmission from the MHb to the IPN. IPN neurons in brain slices were recorded in the whole-
cell voltage-clamp mode. EPSCs were evoked by a train of light stimulation (5 ms, 10Hz; blue bar) of MHb axonal terminals of ChAT-ChR2-EYFP mice.
(A) Light-evoked glutamatergic EPSCs traces from a representative IPN neuron before (black trace and symbols) and during (red traces and symbols) the
application of AM251 (10 mM). Each trace represents the average of three consecutive sweeps. Glutamatergic currents were isolated under constant perfusion of
nicotinic acetylcholine receptors (nAChR) blockers hexamethonium (HMT, 50 mM) and mecamylamine (MEC, 10 mM) and GABAA receptor blocker picrotoxin
(50 mM). The EPSCs were completely abolished by AMPA-type glutamate receptor blocker DNQX (10 mM, green traces and symbols).
(B) Plots depicting the total charge transfer across all EPSCs versus time for the same cell as in (A). Colors indicate the different treatments as in (A).
(C) Summary data of the effect of AM251 on glutamatergic EPSCs (n = 9 cells).
(D) Normalized data of the effect of AM251 on glutamatergic EPSCs (same cells as in (C).
(E–H) The CB1 receptor antagonist AM251 blocks cholinergic transmission from theMHb to the IPN. Cholinergic EPSCswere elicited by a train of light stimulation
of MHb terminals (5 ms, 10 Hz; blue bar) and isolated by DNQX and picrotoxin (black traces and symbols).
(E) Light-evoked cholinergic EPSCs traces from a representative IPN neuron before (black trace and symbols) and during (red traces and symbols) the application
of AM251 (10 mM). AM251 application enhanced the EPSCs of an IPN neuron. These EPSCswere completely blocked by nicotinic blockers HMT (50 mM) andMEC
(10 mM, green traces and symbols), demonstrating their cholinergic nature. Traces represent the average of three consecutive sweeps.
(F) Plots depicting the total charge transfer across all EPSCs versus time for the same cell as in (E). Colors indicate the different treatments as in (E).
(G) Summary data of the AM251 effect on cholinergic EPSCs (n = 8 cells).
(H) Normalized data of the effect of AM251 on cholinergic EPSCs (same cells as in G). ***p < 0.001; **p < 0.01; *p < 0.05; n.s., not significant. For details of
statistical analyses, see Table S1. See also Figure S4.demonstrated (Ren et al., 2011; Stuber et al., 2010; Tecuapetla
et al., 2010; Varga et al., 2009) and could involve specific
anatomical microdomains in single axons (Zhang et al., 2015).
The present data provide an example of the behavioral relevance
of these unconventional synaptic events. Similar to our results,
recent data show that CB1R activity can determine the identity
of the neuromodulators used by single hypothalamic neurons
(Koch et al., 2015). However, the mechanistic explanation of
this neurotransmitter-specific regulation is not currently known.
Frequency-dependent neuronal activity could determine cellular
functions of MHb-CB1R, as previously shown in GABAergic hip-
pocampal neurons (Fo¨ldy et al., 2006).
Presynaptic control of cholinergic transmission by MHb-CB1R
is consistent with the location of CB1R mRNA in the ventral part
of MHb and of CB1R protein in the medial part of the IPN, knownto receive cholinergic MHb inputs (Eckenrode et al., 1987; Hsu
et al., 2014; Ren et al., 2011). CB1R are also present in the dorsal
part of theMHb and at itsmain target region, the lateral portion of
IPN. Nevertheless, our data clearly suggest that this subpopula-
tion of dorsal MHb-CB1R does not participate in the expression
of aversive memories. Previous studies showed that afferents
to the dorsal or ventral parts of the MHb differentially regulate
immediate postshock freezing, in apparent contradiction to our
present results (Yamaguchi et al., 2013). However, by focusing
on the CB1R-dependent presynaptic control of efferent MHb
projections onto long-term fear memory expression, our study
addressed different aspects. As dorsal and ventral MHb affer-
ents and efferents also likely contain presynaptic CB1R, how-
ever, their specific behavioral role(s) will be an interesting issue
for future studies.Neuron 88, 306–313, October 21, 2015 ª2015 Elsevier Inc. 311
The present data are also in agreement with the known ability
of the ECS tomodulate cholinergic transmission in other brain re-
gions (Degroot et al., 2006). In particular, our data clearly indicate
a presynaptic control of cholinergic release at MHb-to-IPN syn-
apses by MHb-CB1R during expression of aversive memories.
Nicotinic receptors play a key role in these mechanisms, but
the exact cellular targets of acetylcholine in this context are still
to be determined. Indeed, nicotinic receptors are present at
postsynaptic sites in the IPN, but also likely at presynaptic level
(autoreceptors) or even on glial cells (Covernton and Lester,
2002; Liu et al., 2015). Thus, it will be interesting to address the
‘‘post-release’’ mechanisms linking CB1R-dependent control of
cholinergic transmission in the IPN to the expression of aversive
memories.
Altogether, this study shows that CB1 receptors control the
expression of aversive memories trough the modulation of
MHb-to-IPN cholinergic, but not glutamatergic, neurotransmis-
sion. Both the MHb and the ECS have been implicated in the
pathogenesis of diseases linked to emotional processing such
as depression, anxiety disorders or drug addiction (Hsu et al.,
2014; Morena and Campolongo, 2014; Sandyk, 1991). Consid-
ering that the control of aversive memories is an integral part
of these disorders, the present data suggest that MHb-CB1R
might represent a potential therapeutic target to tackle important
brain diseases.
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